Jul 29, 2025
Autoantibody spark response predicts treatment outcome in patients receiving chemoradiation followed by durvalumab therapy - New Study
Autoantibody spark response predicts treatment outcome in patients receiving chemoradiation followed by durvalumab therapy Summary A study revealed that the development of new autoantibodies, termed “autoantibody spark,” following chemoradiation therapy (CRT) predicts the effectiveness of subsequent durvalumab immunotherapy in cancer patients. Researchers found that patients exhibiting this…
#Assay systems#Autoantibodies#Autoantibody#Cancer immunotherapy#chemoradiation#durvalumab#Humanities and Social Sciences#ICIs#Immune monitoring#Immunosurveillance#multidisciplinary#Outcome#PACIFIC regimen#patients#Predicts#Prognostic markers#Radiotherapy#receiving#Response#science#spark#Study#therapy#Treatment